Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis
Clinical trial NCT06495593 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06495593
- Sponsor
- University of California, San Francisco
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-04
- Primary completion
- 2027-06-30
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.